Can Neutrophil-Lymphocyte Ratio Be Used to Predict Recurrence and Progression in Non-Muscle Invasive Bladder Cancer?

Can Neutrophil-Lymphocyte Ratio Be Used to Predict Recurrence and Progression in Non-Muscle Invasive Bladder Cancer?

Objective: In this study, we aimed to investigate the predictive value of neutrophil-lymphocyte ratio (NLR) in determining progression and recurrence in non-muscle invasive bladder tumors (NMIBC). Materials and Methods: The files of patients who underwent transurethral bladder tumor resection (TU...

Full description

Bibliographic Details
Main Authors:	Mammadbaghir Aghasiyev, Cemil Kutsal
Format:	Article
Language:	English
Published:	Ekrem Güner 2023-01-01
Series:	Grand Journal of Urology
Subjects:	non-muscle invasive bladder cancer bladder carcinoma neutrophil-lymphocyte ratio recurrence progression
Online Access:	https://grandjournalofurology.com/uploads/pdf/pdf_GJU_76.pdf

Similar Items

Can the neutrophil-to-lymphocyte ratio be used to predict recurrence and progression of non-muscle-invasive bladder cancer?
by: Sebahattin Albayrak, et al.
Published: (2016-06-01)

The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer
by: Mártha Orsolya, et al.
Published: (2020-01-01)

Validation of the importance of neutrophil-to-lymphocyte ratio in non-muscle invasive bladder cancer
by: Porav-Hodade Daniel, et al.
Published: (2022-02-01)

Preoperative neutrophil to lymphocyte ratio improves recurrence prediction of non-muscle invasive bladder cancer
by: Itamar Getzler, et al.
Published: (2018-10-01)

Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
by: Marco Racioppi, et al.

Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer
by: Deng-xiong Li, et al.
Published: (2021-11-01)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
by: Hyeong Dong Yuk, et al.
Published: (2019-01-01)

Clinical significance of preoperative neutrophil to lymphocyte ratio in organ-confined urothelial bladder cancer
by: Engin Kolukcu, et al.
Published: (2021-06-01)

Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
by: Wael Abdo Hassan, et al.
Published: (2023-03-01)

Does the Decrease in Neutrophil-lymphocyte Ratio after BCG Treatment Be a Prognostic Marker for NMIBC?
by: Aykut Başer
Published: (2020-12-01)

Neutrophil-to-lymphocyte ratio (NLR) during induction is a better predictor than preoperative NLR in non-muscle-invasive bladder cancer receiving Bacillus Calmette-GuÉRin
by: Deng-xiong Li, et al.
Published: (2023-03-01)

Prognostic Analysis of Neutrophil/Lymphocyte Ratio and Thrombocyte/Lymphocyte Value Before Trimodal Treatment in Invasive Bladder Cancer
by: Berrin İnanç, et al.
Published: (2020-03-01)

Prognostic Role of Preoperative Neutrophil-To-Lymphocyte Ratio (NLR) and Recurrence at First Evaluation after Bacillus Calmette–Guérin (BCG) Induction in Non-Muscle-Invasive Bladder Cancer
by: Junghoon Lee, et al.
Published: (2023-10-01)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
by: Moniek vanZutphen, et al.
Published: (2023-10-01)

Easily Available Blood Test Neutrophil-To-Lymphocyte Ratio Predicts Progression in High-Risk Non-Muscle Invasive Bladder Cancer
by: Martha Orsolya, et al.
Published: (2017-04-01)

Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study
by: Sanjoy Kumar Sureka, et al.
Published: (2014-01-01)

Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma
by: Tadin Tomislav, et al.
Published: (2012-11-01)

The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
by: Jingqi Zhang, et al.
Published: (2020-03-01)

Non-muscle invasive bladder cancer risk stratification
by: Sumit Isharwal, et al.
Published: (2015-01-01)

Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study
by: Vincenzo Favilla, et al.

The Advanced Age is Effective on Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
by: Goksel Bayar, et al.
Published: (2020-10-01)

Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
by: Matteo Ferro, et al.
Published: (2021-09-01)

Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Predictors Before Treatment for Metastatic Bladder Cancer Patients Receiving First-Line Chemotherapy
by: Oktay Bozkurt, et al.
Published: (2019-09-01)

The Significance of Neutrophil-to-Lymphocyte Ratio and Combined Chemoradiotherapy in Patients Undergoing Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
by: Wu CT, et al.
Published: (2020-12-01)

Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
by: TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong
Published: (2023-05-01)

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups
by: Xuan-Mei Piao, et al.
Published: (2022-11-01)

Prognostic Value of Platelet-to-Lymphocyte Ratio in Non-Muscle Invasive Bladder Cancer Patients: Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor
by: Ruicheng Wu, et al.
Published: (2022-05-01)

Are Preoperative Systemic Immune Index and Neutrophil-to-Lymphocyte Ratio Sufficient to Predict Lymph Node Positivity and Overall Survival in Muscle-Invasive Bladder Cancer Cases?
by: Türev Demirtas, et al.
Published: (2021-09-01)

Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters
by: Yi He, et al.
Published: (2024-03-01)

The Hemoglobin-Red Cell Distribution Width and Neutrophil -Lymphocyte Ratio in Predicting Lamina Propria Invasion in Bladder Tumors?
by: Ali Rıza TÜRKOĞLU, et al.
Published: (2020-08-01)

Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation
by: Sébastien Meunier, et al.
Published: (2023-03-01)

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
by: Takeshi Ieda, M.D., Ph.D., et al.
Published: (2016-10-01)

Applications of Exosomes in Diagnosing Muscle Invasive Bladder Cancer
by: Jillian Marie Walker, et al.
Published: (2022-09-01)

A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients
by: Siteng Chen, et al.
Published: (2021-06-01)

Bladder Preservation with Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for the Treatment of Muscle-invasive Carcinoma of the Bladder: A Single-Center Experience
by: Chinmayee Agrawal, et al.
Published: (2020-07-01)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Kari T. Syvänen, et al.
Published: (2014-05-01)

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer
by: Holz S, et al.
Published: (2017-09-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
by: Dalia Elsayed, et al.
Published: (2023-04-01)

The effect of immediate neoadjuvant electromotive instillation of mitomycin C with Bacillus Calmette–Guérin versus BCG alone in non-muscle-invasive bladder cancer: A randomized controlled trial
by: Abdalla El Azab, et al.
Published: (2023-11-01)

Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle‐invasive bladder cancer after surgery
by: Jincheng Wang, et al.
Published: (2023-07-01)